A Randomized Phase II Study Comparing Bipolar Androgen Therapy vs. Enzalutamide in Asymptomatic Men with Castration Resistant Metastatic Prostate Cancer: The TRANSFORMER Trial (Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance)


Total Award Amount

  • 308040.00
  • Direct Costs

  • 209550.00
  • Sponsor Award Id

  • 2002495982
  • Contributor

  • Mollie Deshazo M.D.   Investigator